Stocks and Investing
Stocks and Investing
Wed, October 6, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, October 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Daina Graybosch Maintained (BNTX) at Hold with Decreased Target to $268 on, Oct 5th, 2021
Daina Graybosch of SVB Leerink, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $293 to $268 on, Oct 5th, 2021.
Daina has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Daina's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
- Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021
These are the ratings of the 3 analyists that currently disagree with Daina
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
- Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
- Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021
Contributing Sources